Treace Medical Concepts, Inc.
TMCI
$4.06
-$0.01-0.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.96M | -9.39M | -16.29M | -17.40M | -15.92M |
| Total Depreciation and Amortization | 899.00K | 1.81M | 2.78M | 2.58M | 2.46M |
| Total Amortization of Deferred Charges | 262.00K | 1.07M | 75.00K | 74.00K | 74.00K |
| Total Other Non-Cash Items | 9.31M | 11.60M | 9.01M | 10.21M | 9.88M |
| Change in Net Operating Assets | 14.73M | -13.11M | -4.67M | 1.49M | 7.70M |
| Cash from Operations | 7.24M | -8.03M | -9.09M | -3.05M | 4.20M |
| Capital Expenditure | -3.06M | -2.40M | -2.81M | -4.77M | -3.54M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.75M | 12.06M | 11.55M | 1.51M | 1.65M |
| Cash from Investing | -7.82M | 9.67M | 8.74M | -3.26M | -1.89M |
| Total Debt Issued | -- | 59.31M | 570.00K | 983.00K | -- |
| Total Debt Repaid | -466.00K | -56.72M | -409.00K | -98.00K | -- |
| Issuance of Common Stock | 91.00K | 70.00K | 241.00K | 116.00K | 119.00K |
| Repurchase of Common Stock | -207.00K | -75.00K | -412.00K | -14.00K | -401.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.00K | -1.20M | -- | -- | -- |
| Cash from Financing | -588.00K | 1.38M | -10.00K | 987.00K | -282.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.16M | 3.02M | -366.00K | -5.32M | 2.02M |